Safety and efficacy of TP10, a complement inhibitor, in adult women undergoing cardiopulmonary bypass surgery

Trial Profile

Safety and efficacy of TP10, a complement inhibitor, in adult women undergoing cardiopulmonary bypass surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2007

At a glance

  • Drugs CDX 1135 (Primary)
  • Indications Angina pectoris; Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Sep 2007 Updated from ADNM 1087473; results reported in Circulation.
    • 19 Jul 2007 Status changed from in progress to completed
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top